The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance
Abstract
PURPOSE OF REVIEW: Unlike Plasmodium falciparum, Plasmodium vivax rarely causes severe disease in healthy travellers or in temperate endemic regions and has been regarded as readily treatable with chloroquine. However, in tropical areas, recent reports have highlighted severe and fatal disease associated with P. vivax infection. We review the evidence for severe disease and the spread of drug-resistant P. vivax and speculate how these maybe related. RECENT FINDINGS: Studies from Indonesia, Papua New Guinea, Thailand and India have shown that 21-27% of patients with severe malaria have P. vivax monoinfection. The clinical spectrum of these cases is broad with an overall mortality of 0.8-1.6%. Major manifestations include severe anaemia and respiratory distress, with infants being particularly vulnerable. Most reports of severe and fatal vivax malaria come from endemic regions where populations have limited access to healthcare, a high prevalence of comorbidity and where drug-resistant P. vivax strains and partially effective primaquine regimens significantly undermine the radical cure and control of this relapsing infection. The mechanisms underlying severe disease in vivax malaria remain poorly defined. SUMMARY: Severe, fatal and multidrug-resistant vivax malaria challenge our perception of P. vivax as a benign disease. Strategies to understand and address these phenomena are needed urgently if the global elimination of malaria is to succeed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effects of Plasmodium vivax malaria in pregnancy.
Nosten, F., McGready, R., Simpson, J., Thwai, K., Balkan, S., Cho, T., Hkirijaroen, L., Looareesuwan, S., & White, N. (1999) · The Lancet · doi:10.1016/s0140-6736(98)09247-2 · Cited by 381
Korenromp, E. L., Williams, B. G., Gouws, E., Dye, C., & Snow, R. W. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00657-1 · Cited by 245
Poespoprodjo, J. R., Fobia, W., Kenangalem, E., Lampah, D. A., Warikar, N., Seal, A., McGready, R., Sugiarto, P., Tjitra, E., Anstey, N. M., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/586743 · Cited by 148
Self-citationCarrara, V. I., Sirilak, S., Thonglairuam, J., Rojanawatsirivet, C., Proux, S., Gilbos, V., Brockman, A., Ashley, E. A., McGready, R., Krudsood, S., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030183 · Cited by 146
Cited by
A Long Neglected World Malaria Map: Plasmodium vivax Endemicity in 2010
Gething, P. W., Elyazar, I. R. F., Moyes, C. L., Smith, D. L., Battle, K. E., Guerra, C. A., Patil, A. P., Tatem, A. J., Howes, R. E., Myers, M. F., et al. (2012) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0001814 · Cited by 538
Self-citationEvidence and Implications of Mortality Associated with Acute Plasmodium vivax Malaria
Baird, J. K. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00074-12 · Cited by 398
Lacerda, M. V., Mourão, M. P., Alexandre, M. A., Siqueira, A. M., Magalhães, B. M., Martinez-Espinosa, F. E., Santana Filho, F. S., Brasil, P., Ventura, A. M., Tada, M. S., et al. (2012) · Malaria Journal · doi:10.1186/1475-2875-11-12 · Cited by 158
Epidemiology, drug resistance, and pathophysiology of Plasmodium vivax malaria
Gowda, D., Dayananda, K., & Achur, R. (2018) · Journal of Vector Borne Diseases · doi:10.4103/0972-9062.234620 · Cited by 111
Treating Severe Malaria in Pregnancy: A Review of the Evidence
Kovacs, S. D., Rijken, M. J., & Stergachis, A. (2015) · Drug Safety · doi:10.1007/s40264-014-0261-9 · Cited by 66
Metadata
- Authors
- Price, R. N., Douglas, N. M., & Anstey, N. M.
- Venue
- Current Opinion in Infectious Diseases
- Published
- 2009-10
- Volume
- 22
- Issue
- 5
- Pages
- 430-435
- ISSN
- 0951-7375 (ISSN-L)
- OpenAlex
- W2010274630
- Cited by
- 343
- References
- 4
- FWCI
- 31.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance. https://app.cochat.ai/papers/10.1097/qco.0b013e32832f14c1
- The paper
- Price, R. N., Douglas, N. M., & Anstey, N. M. (2009). New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance. Current Opinion in Infectious Diseases. https://doi.org/10.1097/qco.0b013e32832f14c1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.